Alpha Cognition appoints Caren Deardorf to board
ACOG•Alpha Cognition appointed Caren Deardorf to its board effective November 11, 2026, and named her to its audit and governance and nomination committees.
1. Board appointment
Alpha Cognition appointed Caren Deardorf to its board on November 5, effective November 11, 2026. She has served as chief business and strategy officer at Neutrolis since August 2025 and previously served as chief commercial and strategy officer at Editas Medicine from 2023 to 2025.
